Literature DB >> 22212850

Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas.

Rohit R Das1, Elinor Artsy, Shelley Hurwitz, Patrick Y Wen, Peter Black, Alexandra Golby, Barbara Dworetzky, Jong Woo Lee.   

Abstract

Low grade tumors are associated with a high risk of seizures. Prolonged use of antiepileptic drugs (AEDs) is associated with morbidity. Determining which patients can safely discontinue AEDs perioperatively is difficult. We examined patients with low grade supratentorial brain tumors to determine characteristics of patients who underwent AED withdrawal. A retrospective chart review was performed in patients who underwent resection between 1/1/2004 and 12/31/2005 at a single center. Data were collected regarding the use of postoperative AEDs, occurrence of postoperative seizures, and patient/tumor characteristics. We examined 169 patients with a median follow-up of 3.1 years. AEDs were withdrawn or never started in 111 patients; post-withdrawal seizures occurred in 11 (9.9%). The rate was similar between meningiomas and primary brain tumors. No independent risk factors for post-withdrawal seizures were found. Of 58 patients whose AEDs were not withdrawn, postoperative seizures occurred in 28 (48%). Predictors of AED continuation included existence of preoperative seizures, temporal tumor location, tumor recurrence, incomplete resection, and male sex. The decision to continue AEDs was predictive for postoperative seizures even after controlling for known risk factors. Although clinicians are able to identify patients at high risk for postoperative seizures, treatment with AEDs is ineffective in many patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22212850     DOI: 10.1007/s11060-011-0779-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

Review 1.  Optimizing therapy of seizures in patients with brain tumors.

Authors:  Charles J Vecht; Melanie van Breemen
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

2.  Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors.

Authors:  Vitaly Siomin; Lilyana Angelov; Liang Li; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 3.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

4.  The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Christian E Elger; Otmar D Wiestler; Johannes Schramm
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

5.  Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors.

Authors:  Raja B Khan; Arzu Onar
Journal:  Epilepsia       Date:  2006-02       Impact factor: 5.864

Review 6.  Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography.

Authors:  F T Vertosick; R G Selker; V C Arena
Journal:  Neurosurgery       Date:  1991-04       Impact factor: 4.654

7.  Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider.

Authors:  David Aguiar; Roberto Pazo; Ignacio Durán; Josefa Terrasa; Antonio Arrivi; Herminio Manzano; Javier Martín; Julio Rifá
Journal:  J Neurooncol       Date:  2004-02       Impact factor: 4.130

8.  Seizure characteristics and control following resection in 332 patients with low-grade gliomas.

Authors:  Edward F Chang; Matthew B Potts; G Evren Keles; Kathleen R Lamborn; Susan M Chang; Nicholas M Barbaro; Mitchel S Berger
Journal:  J Neurosurg       Date:  2008-02       Impact factor: 5.115

9.  Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.

Authors:  Martin Klein; Nadine H J Engelberts; Henk M van der Ploeg; Dorotheé G A Kasteleijn-Nolst Trenité; Neil K Aaronson; Martin J B Taphoorn; Hans Baaijen; W Peter Vandertop; Martin Muller; Tjeerd J Postma; Jan J Heimans
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

10.  Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review.

Authors:  Laura M Lynam; Mark K Lyons; Joseph F Drazkowski; Joseph I Sirven; Katherine H Noe; Richard S Zimmerman; James A Wilkens
Journal:  Clin Neurol Neurosurg       Date:  2007-06-29       Impact factor: 1.876

View more
  12 in total

1.  Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

Authors:  Barbara Schmeiser; Bernhard J Steinhoff; Andreas Schulze-Bonhage
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 2.  Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review.

Authors:  Johan A F Koekkoek; Melissa Kerkhof; Linda Dirven; Jan J Heimans; Jaap C Reijneveld; Martin J B Taphoorn
Journal:  Neuro Oncol       Date:  2015-03-25       Impact factor: 12.300

3.  Management of epilepsy in brain tumors.

Authors:  Marta Maschio; Umberto Aguglia; Giuliano Avanzini; Paola Banfi; Carla Buttinelli; Giuseppe Capovilla; Marina Maria Luisa Casazza; Gabriella Colicchio; Antonietta Coppola; Cinzia Costa; Filippo Dainese; Ornella Daniele; Roberto De Simone; Marica Eoli; Sara Gasparini; Anna Teresa Giallonardo; Angela La Neve; Andrea Maialetti; Oriano Mecarelli; Marta Melis; Roberto Michelucci; Francesco Paladin; Giada Pauletto; Marta Piccioli; Stefano Quadri; Federica Ranzato; Rosario Rossi; Andrea Salmaggi; Riccardo Terenzi; Paolo Tisei; Flavio Villani; Paolo Vitali; Lucina Carla Vivalda; Gaetano Zaccara; Alessia Zarabla; Ettore Beghi
Journal:  Neurol Sci       Date:  2019-08-07       Impact factor: 3.307

4.  What is New in the Management of Epilepsy in Gliomas?

Authors:  Roberta Rudà; Riccardo Soffietti
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

Review 5.  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.

Authors:  Terri S Armstrong; Robin Grant; Mark R Gilbert; Jong Woo Lee; Andrew D Norden
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

Review 6.  Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies.

Authors:  Adrianna Ranger; David Diosy
Journal:  Childs Nerv Syst       Date:  2015-03-21       Impact factor: 1.475

7.  Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.

Authors:  Johan A F Koekkoek; Melissa Kerkhof; Linda Dirven; Jan J Heimans; Tjeerd J Postma; Maaike J Vos; Jacoline E C Bromberg; Martin J van den Bent; Jaap C Reijneveld; Martin J B Taphoorn
Journal:  BMC Neurol       Date:  2014-08-15       Impact factor: 2.474

8.  Early and Late Postoperative Seizures in Meningioma Patients and Prediction by a Recent Scoring System.

Authors:  Peter Baumgarten; Mana Sarlak; Daniel Monden; Andrea Spyrantis; Simon Bernatz; Florian Gessler; Daniel Dubinski; Elke Hattingen; Gerhard Marquardt; Adam Strzelczyk; Felix Rosenow; Patrick N Harter; Volker Seifert; Thomas M Freiman
Journal:  Cancers (Basel)       Date:  2021-01-25       Impact factor: 6.639

9.  Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures.

Authors:  Sankalp Gokhale; Shariq Ali Khan; Abhishek Agrawal; Allan H Friedman; David L McDonagh
Journal:  Asian J Neurosurg       Date:  2013-10

10.  SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.

Authors:  Tobias Walbert; Rebecca A Harrison; David Schiff; Edward K Avila; Merry Chen; Padmaja Kandula; Jong Woo Lee; Emilie Le Rhun; Glen H J Stevens; Michael A Vogelbaum; Wolfgang Wick; Michael Weller; Patrick Y Wen; Elizabeth R Gerstner
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.